Other Species / Isoforms
  SRPK2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S10
VNSEKSSsSERPEPQ
Upstream
0 11
Treatment
  • metformin
SRPK2 (human) VNSEKSSsSERPEPQ S10
SRPK2 iso2 (human) gap -
SRPK2 (mouse) VNSEKSSsSERPEPQ S10
SRPK2 (rat) VNSEKSSSSERPEPQ S10
S52
PEEEILGsDDEEQED
0 9
SRPK2 (human) PEEEILGsDDEEQED S52
SRPK2 iso2 (human) PEEEILGSDDEEQED S63
SRPK2 (mouse) PEEEILGsDDEEQED S50
SRPK2 (rat) PEEEILGSDDEEQED S50
Y182
KWIIKSNyQGLPVRC
0 111
SRPK2 (human) KWIIKSNyQGLPVRC Y182
SRPK2 iso2 (human) KWIIKSNYQGLPVRC Y193
SRPK2 (mouse) KWIIKSNYQGLPVRC Y180
SRPK2 (rat) KWIIKSNYQGLPVRC Y180
S250
GAPPPSGsAVSTAPQ
0 1
SRPK2 (human) GAPPPSGsAVSTAPQ S250
SRPK2 iso2 (human) GAPPPSGSAVSTAPQ S261
SRPK2 (mouse) GAPPPSGSAVSTAPQ S248
SRPK2 (rat) GAPPPSGSAVSTAPQ S248
S312
NITSAAPsNDQDGEy
0 3
SRPK2 (human) NITSAAPsNDQDGEy S312
SRPK2 iso2 (human) NITSAAPSNDQDGEY S323
SRPK2 (mouse) gap -
SRPK2 (rat) NTTSAEAssEQDGEC S310
N313
ITSAAPsNDQDGEyC
0 1
SRPK2 (human) ITSAAPsNDQDGEyC N313
SRPK2 iso2 (human) ITSAAPSNDQDGEYC N324
SRPK2 (mouse) NITSAEASGEQDGEY S310
SRPK2 (rat) TTSAEAssEQDGECQ S311
Y319
sNDQDGEyCPEVKLK
0 165
SRPK2 (human) sNDQDGEyCPEVKLK Y319
SRPK2 iso2 (human) SNDQDGEYCPEVKLK Y330
SRPK2 (mouse) SGEQDGEYQPEVTLK Y317
SRPK2 (rat) ssEQDGECQPEVKLK C317
T328
PEVKLKTtGLEEAAE
0 1
SRPK2 (human) PEVKLKTtGLEEAAE T328
SRPK2 iso2 (human) PEVKLKTTGLEEAAE T339
SRPK2 (mouse) PEVTLKAADLEDttE A326
SRPK2 (rat) PEVKLKEAELEDttE A326
A333
KTtGLEEAAEAETAK
0 11
SRPK2 (human) KTtGLEEAAEAETAK A333
SRPK2 iso2 (human) KTTGLEEAAEAETAK A344
SRPK2 (mouse) KAADLEDttEEETAK T331
SRPK2 (rat) KEAELEDttEEETAK T331
A334
TtGLEEAAEAETAKD
0 11
SRPK2 (human) TtGLEEAAEAETAKD A334
SRPK2 iso2 (human) TTGLEEAAEAETAKD A345
SRPK2 (mouse) AADLEDttEEETAKD T332
SRPK2 (rat) EAELEDttEEETAKD T332
A354
DQEEKEDAEKENIEK
0 1
SRPK2 (human) DQEEKEDAEKENIEK A354
SRPK2 iso2 (human) DQEEKEDAEKENIEK A365
SRPK2 (mouse) DQEEKEDAEKENAEK A352
SRPK2 (rat) DQEEKEDtEKENtEK T352
I359
EDAEKENIEKDEDDV
0 1
SRPK2 (human) EDAEKENIEKDEDDV I359
SRPK2 iso2 (human) EDAEKENIEKDEDDV I370
SRPK2 (mouse) EDAEKENAEKDEDDV A357
SRPK2 (rat) EDtEKENtEKDEDDV T357
T376
ELANIDPtWIEsPKT
0 1
SRPK2 (human) ELANIDPtWIEsPKT T376
SRPK2 iso2 (human) ELANIDPTWIESPKT T387
SRPK2 (mouse) ELANLDPTWVEsPKA T374
SRPK2 (rat) ELENIDPTWMEsPKA T374
S380
IDPtWIEsPKTNGHI
Upstream
0 19
Treatment
  • nocodazole
  • thymidine
SRPK2 (human) IDPtWIEsPKTNGHI S380
SRPK2 iso2 (human) IDPTWIESPKTNGHI S391
SRPK2 (mouse) LDPTWVEsPKANGHI S378
SRPK2 (rat) IDPTWMEsPKANGHI S378
S423
LDEPNAEsDYTySSS
0 1
SRPK2 (human) LDEPNAEsDYTySSS S423
SRPK2 iso2 (human) LDEPNAESDYTYSSS S434
SRPK2 (mouse) LDEPNAESDYTYSSs S421
SRPK2 (rat) LDEPNAESDYTYSSS S421
Y427
NAEsDYTySSSYEQF
0 1
SRPK2 (human) NAEsDYTySSSYEQF Y427
SRPK2 iso2 (human) NAESDYTYSSSYEQF Y438
SRPK2 (mouse) NAESDYTYSSsYEQF Y425
SRPK2 (rat) NAESDYTYSSSYEQF Y425
S430
sDYTySSSYEQFNGE
0 1
SRPK2 (human) sDYTySSSYEQFNGE S430
SRPK2 iso2 (human) SDYTYSSSYEQFNGE S441
SRPK2 (mouse) SDYTYSSsYEQFNGE S428
SRPK2 (rat) SDYTYSSSYEQFNGE S428
I445
LPNGRHKIPESQFPE
0 1
SRPK2 (human) LPNGRHKIPESQFPE I445
SRPK2 iso2 (human) LPNGRHKIPESQFPE I456
SRPK2 (mouse) LPNGQHKTSEFPTPL T443
SRPK2 (rat) LPNGQPKsPEFPTPL S443
S459
EFSTSLFSGSLEPVA
0 1
SRPK2 (human) EFSTSLFSGSLEPVA S459
SRPK2 iso2 (human) EFSTSLFSGSLEPVA S470
SRPK2 (mouse) EFPTPLFsGPLEPVA S452
SRPK2 (rat) EFPTPLFSGPLEPVA S452
S469
LEPVACGSVLSEGSP
0 1
SRPK2 (human) LEPVACGSVLSEGSP S469
SRPK2 iso2 (human) LEPVACGSVLSEGSP S480
SRPK2 (mouse) LEPVACGsVIsEGsP S462
SRPK2 (rat) LEPVASDSVLSEGSP S462
S472
VACGSVLSEGSPLTE
0 2
SRPK2 (human) VACGSVLSEGSPLTE S472
SRPK2 iso2 (human) VACGSVLSEGSPLTE S483
SRPK2 (mouse) VACGsVIsEGsPLtE S465
SRPK2 (rat) VASDSVLSEGSPLtE S465
S475
GSVLSEGSPLTEQEE
0 3
SRPK2 (human) GSVLSEGSPLTEQEE S475
SRPK2 iso2 (human) GSVLSEGSPLTEQEE S486
SRPK2 (mouse) GsVIsEGsPLtEQEE S468
SRPK2 (rat) DSVLSEGSPLtEPEE S468
T478
LSEGSPLTEQEEssP
0 3
SRPK2 (human) LSEGSPLTEQEEssP T478
SRPK2 iso2 (human) LSEGSPLTEQEESSP T489
SRPK2 (mouse) IsEGsPLtEQEEssP T471
SRPK2 (rat) LSEGSPLtEPEESSP T471
S483
PLTEQEEssPSHDRS
0 3
SRPK2 (human) PLTEQEEssPSHDRS S483
SRPK2 iso2 (human) PLTEQEESSPSHDRS S494
SRPK2 (mouse) PLtEQEEssPsHDRs S476
SRPK2 (rat) PLtEPEESSPSRDRS S476
S484
LTEQEEssPSHDRSR
0 5
SRPK2 (human) LTEQEEssPSHDRSR S484
SRPK2 iso2 (human) LTEQEESSPSHDRSR S495
SRPK2 (mouse) LtEQEEssPsHDRsR S477
SRPK2 (rat) LtEPEESSPSRDRSR S477
S486
EQEEssPSHDRSRtV
0 1
SRPK2 (human) EQEEssPSHDRSRtV S486
SRPK2 iso2 (human) EQEESSPSHDRSRTV S497
SRPK2 (mouse) EQEEssPsHDRsRtV S479
SRPK2 (rat) EPEESSPSRDRSRtV S479
S490
ssPSHDRSRtVsAss
0 1
SRPK2 (human) ssPSHDRSRtVsAss S490
SRPK2 iso2 (human) SSPSHDRSRTVSASS S501
SRPK2 (mouse) ssPsHDRsRtVsAss S483
SRPK2 (rat) SSPSRDRSRtVsASs S483
T492
PSHDRSRtVsAsstG
Upstream
Downstream
3 6
Effects on Modified Protein
  • enzymatic activity, induced
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
  • transcription, altered
Kinase, in vitro:
  • Akt1 (human)
Putative in vivo kinases:
  • Akt1 (human)
Treatment
  • EGF
  • GF109203X
  • LY294002
  • PD98059
  • wortmannin
view more >
SRPK2 (human) PSHDRSRtVsAsstG T492
SRPK2 iso2 (human) PSHDRSRTVSASSTG T503
SRPK2 (mouse) PsHDRsRtVsAsstG T485
SRPK2 (rat) PSRDRSRtVsASstG T485
S494
HDRSRtVsAsstGDL
Upstream
Downstream
1 73
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • transcription, induced
Kinase, in vitro:
  • SRPK2 (human)
Putative in vivo kinases:
  • p70S6K (human)
Regulatory protein:
  • CD38 (human)
  • PRP4 (human)
Treatment
  • angiotensin_2
  • antibody
  • EGF
  • insulin
  • ischemia
  • MK-2206
  • PF-4708671
  • rapamycin
  • SB202190
  • selumetinib
  • Torin1
  • U0126
  • vemurafenib
view more >
SRPK2 (human) HDRSRtVsAsstGDL S494
SRPK2 iso2 (human) HDRSRTVSASSTGDL S505
SRPK2 (mouse) HDRsRtVsAsstGDL S487
SRPK2 (rat) RDRSRtVsASstGDL S487
S496
RSRtVsAsstGDLPK
Upstream
0 9
Regulatory protein:
  • CD38 (human)
SRPK2 (human) RSRtVsAsstGDLPK S496
SRPK2 iso2 (human) RSRTVSASSTGDLPK S507
SRPK2 (mouse) RsRtVsAsstGDLPK S489
SRPK2 (rat) RSRtVsASstGDLPK S489
S497
SRtVsAsstGDLPKA
Upstream
Downstream
1 48
SRPK2 (human)
S497
SRPK2 iso2 (human)
S508
SRPK2 (mouse)
S490
SRPK2 (rat)
S490
Effects on Modified Protein
  • intracellular localization
  • phosphorylation
Effects on Biological Processes:
  • transcription, induced
Kinase, in vitro:
  • CK1A (human)
Treatment
  • angiotensin_2
  • EGF
  • insulin
  • MK-2206
  • PF-4708671
  • rapamycin
  • SB202190
  • Torin1
  • vemurafenib
view more >
SRPK2 (human) SRtVsAsstGDLPKA S497
SRPK2 iso2 (human) SRTVSASSTGDLPKA S508
SRPK2 (mouse) sRtVsAsstGDLPKT S490
SRPK2 (rat) SRtVsASstGDLPKT S490
T498
RtVsAsstGDLPKAK
Upstream
0 18
Treatment
  • selumetinib
  • vemurafenib
SRPK2 (human) RtVsAsstGDLPKAK T498
SRPK2 iso2 (human) RTVSASSTGDLPKAK T509
SRPK2 (mouse) RtVsAsstGDLPKTK T491
SRPK2 (rat) RtVsASstGDLPKTK T491
T547
HFTEDIQtRQYRSIE
0 17
SRPK2 (human) HFTEDIQtRQYRSIE T547
SRPK2 iso2 (human) HFTEDIQTRQYRSIE T558
SRPK2 (mouse) HFTEDIQtRQYRSIE T540
SRPK2 (rat) HFTEDIQTRQYRSIE T540
S608
HIIELLGsIPRHFAL
0 2
SRPK2 (human) HIIELLGsIPRHFAL S608
SRPK2 iso2 (human) HIIELLGSIPRHFAL S619
SRPK2 (mouse) HIIELLGsIPRHFAL S601
SRPK2 (rat) HIIELLGSIPRHFAL S601
S616
IPRHFALsGKYSREF
0 1
SRPK2 (human) IPRHFALsGKYSREF S616
SRPK2 iso2 (human) IPRHFALSGKYSREF S627
SRPK2 (mouse) IPRHFALSGKYSREF S609
SRPK2 (rat) IPRHFALSGKYSREF S609